Lipid Nanoparticles Industry Overview
The lipid nanoparticles market is semi-consolidated in nature due to the presence of some key players operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies that hold considerable market share and are well known. They include Merck KGaA, Croda International PLC, Cytiva, BIOVECTRA, Acuitas Therapeutics, CordenPharma, Genevant Sciences Corporation, Arcturus Therapeutics Inc., Ascendia Pharmaceuticals, and CD Bioparticles.
Lipid Nanoparticles Market Leaders
-
Merck KGaA
-
Arcturus Therapeutics, Inc.
-
Ascendia Pharmaceuticals
-
Acuitas Therapeutics
-
Croda International Plc.
- *Disclaimer: Major Players sorted in no particular order